Schedule 13G ownership disclosure

SANGAMO BIOSCIENCES INC

Security class unavailable · CUSIP: 800677106

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,840,682
Percent of class
6.7600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-20-000241
Form type
SC 13G
Filer
SANGAMO THERAPEUTICS, INC
CIK
CIK 1001233
Filed
Jan 28, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub